Abstract:Nanotechnology-based drug delivery systems, including siRNA, present an innovative approach to treating breast cancer, which disproportionately affects women. These systems enable personalized and targeted therapies, adept at managing drug resistance and minimizing off-target effects. This review delves into the current landscape of nanotechnology-derived siRNA transport systems for breast cancer treatment, discussing their mechanisms of action, preclinical and clinical research, therapeutic applications, challenges, and future prospects. Emphasis is placed on the importance of targeted delivery and precise gene silencing in improving therapeutic efficacy and patient outcomes. The review addresses specific hurdles such as specificity, biodistribution, immunological reactions, and regulatory approval, offering potential solutions and avenues for future research. SiRNA drug delivery systems hold promise in revolutionizing cancer care and improving patient outcomes, but realizing their full potential necessitates ongoing research, innovation, and collaboration. Understanding the intricacies of siRNA delivery mechanisms is pivotal for designing effective cancer treatments, overcoming challenges, and advancing siRNA-based therapies for various diseases, including cancer. The article provides a comprehensive review of the methods involved in siRNA transport for therapeutic applications, particularly in cancer treatment, elucidating the complex journey of siRNA molecules from extracellular space to intracellular targets. Key mechanisms such as endocytosis, receptor-mediated uptake, and membrane fusion are explored, alongside innovative delivery vehicles and technologies that enhance siRNA delivery efficiency. Moreover, the article discusses challenges and opportunities in the field, including issues related to specificity, biodistribution, immune response, and clinical translation. By comprehending the mechanisms of siRNA delivery, researchers can design and develop more effective siRNA-based therapies for various diseases, including cancer.

Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges

Exosomes: Promising Nanocarrier for Cancer Therapy

Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies

Recent advances in exosome-mediated nucleic acid delivery for cancer therapy

Exosome as a Delivery Vehicle for Cancer Therapy

Engineered Exosomes As Drug and RNA Co-Delivery System: New Hope for Enhanced Therapeutics?

Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics

Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?

Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer

Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics

Efficient nanocarriers of siRNA therapeutics for cancer treatment

Exosomes as Drug Delivery Vehicles for Cancer Treatment

Precision arrows: Navigating breast cancer with nanotechnology siRNA

Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics

Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy

Exosomes As Drug Carriers for Clinical Application

Engineered Exosomes as Theranostic Platforms for Cancer Treatment

Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application

Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: Recent advances and challenges

Nanoparticle‐Mediated Sirna Delivery and Multifunctional Modification Strategies for Effective Cancer Therapy

Exosome-based nanoparticles and cancer immunotherapy